Crossmark

The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma

Crossref DOI link: https://doi.org/10.1007/s11864-019-0622-9

Published Online: 2019-02-18

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsieh, Chi-Che

Shen, Che-Hung
License Information

Text and Data Mining valid from 2019-02-18
More Information

Article History

First Online: 18 February 2019

Compliance with Ethical Standards

:

: Chi-Che Hsieh and Che-Hung Shen declare they have no conflict of interest.

: This article does not contain any studies with human or animal subjects performed by any of the authors.